BIT's 9th Annual World Congress of Molecular & Cell Biology (CMCB-2019)
About the Conference

Following the successful organizing of CMCB in the past 8 years, CMCB-2019 will provide a platform for participants to share their new findings and discuss the unsolved mysteries in Molecular & Cell Biology. The organizing committee of CMCB-2019 is also dedicated in bringing to the scientific community the most cutting-edge technologies and their application in the field. We aim to bring together experts from academia, research institutions and industry and key-decision makers to participate in the congress. During the congress, we will set up a series of activities such as Scientific Programs, Poster Sessions, Thematic Biotechnology and Economic Forums and Exhibits for participants.

Highlights of the Conference

● 1 Plenary Forum from a Panel of Leading Experts in Molecular & Cell Biology
● 200+ Oral Presentations on the Latest Molecular & Cell Biology Development 
● 50+ Project Posters on Medical Research, Clinical Research & Discovery
● 500+ Professional Attendees from All over the World for Unrivalled Networking
● Opportunity to Present Your Work and Forge New Collaborations
● Tech Tour to Famous Science Spots & Cultural Landscapes in Singapore

Dr. Zang-Hee Cho received Ph.D. at Uppsala University (Sweden) in 1966 and has been faculty at the University of Stockholm and University of California-Los Angeles. In 1979, Dr. Cho moved to Columbia University as a Professor of Radiology (Physics) and served as a co-Director of Columbia University Imaging Center until 1984 before he joined University of California, Irvine (UCI). Since 1985, Dr. Cho was the Professor of Radiological Science at University of California at Irvine until 2006. From 2006 to 2014, Professor Cho, the University Professor at the Neuroscience Research Institute, Gachon University of Medicine & Science, Incheon, Korea. Dr. Cho moved to Advanced Institutes of Convergence Technology (AICT), Seoul National University, as a Distinguished Research Fellow, since 2015. Professor Cho has been a pioneer in Positron Emission Tomography (PET) and Magnetic Resonance Imaging since the inception of the computerized tomography (CT) in 1972. He was the first one who pioneered world’s first "Ring PET" in 1975 and its nuclear detector "Bismuth Germanate Oxide (BGO)" in 1976, both of which revolutionized modern brain-imaging. More recently, professor Cho pioneered the first PET-MRI (Proteomics 2008) demonstrating that in-vivo submillimeter high resolution molecular imaging is possible. This pioneering work now accepted as an important new approach to the molecular imaging in human brain imaging in-vivo. Among the numerous honors and awards, Professor Cho was elected as a member of the US National Academy of Sciences- Institute of Medicine in 1997.

Dr. George R. Lee received his medical degree from the Medical College of Georgia. He subsequently completed his internship in internal medicine at the University of Alabama, School of Medicine and his neurology residency at Vanderbilt University Medical Center. He continued his training at Vanderbilt University as a clinical neurophysiology fellow and served as the chief fellow. He currently holds an appointed position as Assistant Clinical Professor of Neurology with the Department of Neurology at Vanderbilt University Medical Center. He is the president and chairman of the board for Real Time Neuromonitoring Associates, PC and affiliated entities. He also serves as the medical director of the Vanderbilt Neurodiagnostic Technologist Training Program for which he helped found and obtain accreditation. His clinical focus is on providing intraoperative neuromonitoring and neurodiagnostic studies. Dr. Lee maintains licensure in Tennessee and 46 other states plus the District of Columbia. He has served on the Board of Directors of the American Society of Neurophysiological Monitoring (ASNM) and as its president and chairman of the board. He also has served on the board of the Tennessee Medical Association, board of Tennessee Medical Education Fund, Independent Medicine's Political Action Committee of Tennessee (IMPACT), the Tennessee Physician Leadership College Steering Committee, and the national Committee on Accreditation for Education in Neurodiagnostic Technology (CoA-NDT). He frequently presents at national and international conferences on the topics of intraoperative neuromonitoring practices, quality, evidence, medicolegal, and business. He has received leadership awards by the American Medical Association and the American Academy of Neurology and most recently received an outstanding entrepreneur award from Emory University.
Keynote Speakers of CMCB-2019
Mr. Richard J. Fish
President and CEO
Alter NRG Corp., USA
210px-JenaPotrait-1 Dr. Andrew Potter,
Professor & Associate Vice President Research, University of Saskatchewan, Canada
Dr. Reiko Kuroda
Chubu University
Dr. Hwa A. Lim,
CEO, D'Trends, Inc., USA
Dr. Patrick M.F. Derkx,
Vice President R&D, Chr. Hansen A/S, Denmark
Renowned Speakers of CMCB-2019
Dr. Bhanu P. Jena
Wayne State University 
School of Medicine, USA
Dr. Altaf A. Wani
The Ohio State University, USA
Mr. Richard J. Fish
President and CEO
Alter NRG Corp., USA
Dr. Anita Franczak
University of Warmia and
Mazury in Olsztyn, Poland
Dr. M. E. Hammadeh
University of Saarland, Germany
Dr. W. Robert McMaster
University of British Columbia, Canada
Dr. Luigi Puglielli
University of Wisconsin-
Madison, USA
Dr. Hans-Gert Bernstein
Associate Professor
University of Magdeburg, Germany
Dr. Wing-Yee Lui
Associate Professor
The University of Hong Kong, Hong Kong, China
Dr. Mark A. Sheridan
Texas Tech University, USA
Dr. Samir A Ross
University of Mississippi, USA
Dr. Danny Huylebroeck
Erasmus MC, The Netherlands
Dr. John S. Pixley
Texas Tech University Health Science Center, USA
Dr. Toshifumi Tsukahara
Japan Advanced Institute of Science and Technology, Japan
Dr. Guoping Zheng
Senior Research Fellow
University of Sydney, Australia
Dr. Markku Ryynanen M
Obstetrics and Gynecology,
Oulu University Hospital,
Dr. Warren Ladiges
University of Washington, USA
Dr. King-Thom Chung
University of Memphis, USA
Dr. Manoj Gupta,
Associate Professor, National University of Singapore, Singapore
Exhibition and Poster

CMCB-2019 provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you. And it is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations. More...

Introduction of Singapore
Singapore, officially the Republic of Singapore, is an island country located at the southern tip of the Malay Peninsula. Though physically small, Singapore is an economic giant. It has been Southeast Asia's most modern city for over a century. Its unique ethnic tapestry affords visitors a wide array of sightseeing and culinary opportunities from which to choose. A full calendar of traditional festivals and holidays celebrated throughout the year adds to its cultural appeal. The country includes the island of Singapore and 63 smaller islands. Because of its efficient and determined government, Singapore has become a flourishing country that excels in trade and tourism and is a model to developing nations.
Online Registration
News Released

● The scientific program has updated
● Call for speakers, exhibitors and sponsors worldwide.
● Call for media partners and advertiser worldwide.     
● Call for paper

Hosting Organization

National Foreign Experts Databank of MOST (Dalian Branch)

Operating Organization

BIT Group Global Ltd.

Official Travel Agency

BIT World Travel Service, Inc.

Honorary Chairmen

Dr. Bhanu P. Jena
George E. Palade University Professor & Distinguished Professor
Wayne State University 
School of Medicine, USA

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2011-2019 BIT Congress Inc.